Clinical trial
Lamotrigine Monotherapy in Pediatric Bipolar Disorder
NCT00176228 · University of Illinois at Chicago, Other · Completed
Key facts
| NCT number | NCT00176228 |
|---|---|
| Title | Lamotrigine Monotherapy in Pediatric Bipolar Disorder |
| Official title | Open Trial of Lamotrigine Monotherapy in Pediatric Bipolar Disorder |
| Lead sponsor | University of Illinois at Chicago, Other |
| Collaborators | GlaxoSmithKline Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Bipolar Disorder |
| Intervention type | Drug |
| Interventions | Lamotrigine |
| Enrollment | 48 |
| Start date | Feb 1, 2004 |
| Primary completion | Jan 1, 2008 |
| Completion | Jan 1, 2008 |
| First posted | Sep 15, 2005 |
| Last update posted | Jul 30, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: